Mrs
Dr
Miss
Ms
Prof
Printer Friendly
Printed from http://www.researchandmarkets.com/reports/1322600
Flamel Technologies S.A. (FLML) - Financial and Strategic SWOT Analysis Review
Description:
Flamel Technologies S.A. (FLML) - Financial and Strategic SWOT Analysis Review
Summary
Flamel Technologies S.A. (Flamel) is a biopharmaceutical company that is engaged in the development of two polymer-based drug delivery technologies for the improvement of medical applications. The key technologies of the company includes nanogel Medusa technology, Micropump technology, Trigger-Lock technology and LiquiTime technology. The company is developing drugs like Interferon-Alpha XL and FT-105 based on its Medusa technology and products like COREG CR and other products for pain based on its Micropump development platform. It secures patents and other intellectual property rights over its innovations and developments and holds various patents. Flamel has a manufacturing plant at Pessac Cedex, France. The company is headquartered in Venissieux Cedex, France.
Flamel Technologies S.A. Key Recent Developments
Jul 25, 2011 Flamel Technologies Reports Total Revenue Of $6.8m For Q2 2011
May 09, 2011 Flamel Technologies Reports Net Loss Of $4.9m For Q1 2011
May 04, 2011 Flamel Technologies Files Lawsuit Against Lupin
Mar 03, 2011 Flamel Reports Net Income Of $2.7m For Q4 2010
Nov 04, 2010 Flamel Reports Net Loss Of $3.3 Million For Q3 2010
This comprehensive SWOT profile of Flamel Technologies S.A. provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Summary
Flamel Technologies S.A. (Flamel) is a biopharmaceutical company that is engaged in the development of two polymer-based drug delivery technologies for the improvement of medical applications. The key technologies of the company includes nanogel Medusa technology, Micropump technology, Trigger-Lock technology and LiquiTime technology. The company is developing drugs like Interferon-Alpha XL and FT-105 based on its Medusa technology and products like COREG CR and other products for pain based on its Micropump development platform. It secures patents and other intellectual property rights over its innovations and developments and holds various patents. Flamel has a manufacturing plant at Pessac Cedex, France. The company is headquartered in Venissieux Cedex, France.
Flamel Technologies S.A. Key Recent Developments
Jul 25, 2011 Flamel Technologies Reports Total Revenue Of $6.8m For Q2 2011
May 09, 2011 Flamel Technologies Reports Net Loss Of $4.9m For Q1 2011
May 04, 2011 Flamel Technologies Files Lawsuit Against Lupin
Mar 03, 2011 Flamel Reports Net Income Of $2.7m For Q4 2010
Nov 04, 2010 Flamel Reports Net Loss Of $3.3 Million For Q3 2010
This comprehensive SWOT profile of Flamel Technologies S.A. provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Contents:
List of Tables
List of Figures
Section 1 - About the Company
Flamel Technologies S.A. - Key Facts
Flamel Technologies S.A. - Key Employees
Flamel Technologies S.A. - Key Employee Biographies
Flamel Technologies S.A. - Major Products and Services
Flamel Technologies S.A. - Pharmaceutical Pipeline Products Data
Flamel Technologies S.A., Pipeline Products by Therapy Area
Flamel Technologies S.A., Pipeline Products by Development Phase
Flamel Technologies S.A. - History
Flamel Technologies S.A. - Company Statement
Flamel Technologies S.A. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Flamel Technologies S.A. - Key Manufacturing Facilities
Section 2 – Company Analysis
Flamel Technologies S.A. - Business Description
Flamel Technologies S.A. - SWOT Analysis
SWOT Analysis - Overview
Flamel Technologies S.A. - Strengths
Strength - Unique Polymer-Based Drug Delivery Platforms
Strength - Coreg CR-Lead product
Strength - Strategic Agreements
Weakness - Dependence on Limited Customers
Weakness - Weak Liquidity Position
Weakness - Dependence on Single Manufacturing Unit
Opportunity - Emerging Markets
Opportunity - Need for Novel Delivery Systems
Opportunity - Changing Demographics
Threat - Intense Competition
Threat - Uncertain R&D Outcomes
Threat - Growing Parallel Trade
Flamel Technologies S.A. - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Flamel Technologies S.A., Pharmaceuticals & Healthcare, Deals By Year, 2005 to YTD 2011
Flamel Technologies S.A., Pharmaceuticals & Healthcare, Deals By Type, 2005 to YTD 2011
Flamel Technologies S.A., Recent Deals Summary
Section 5 – Company’s Recent Developments
Jul 25, 2011: Flamel Technologies Reports Total Revenue Of $6.8m For Q2 2011
May 09, 2011: Flamel Technologies Reports Net Loss Of $4.9m For Q1 2011
May 04, 2011: Flamel Technologies Files Lawsuit Against Lupin
Mar 03, 2011: Flamel Reports Net Income Of $2.7m For Q4 2010
Nov 04, 2010: Flamel Reports Net Loss Of $3.3 Million For Q3 2010
Jul 28, 2010: Flamel Reports Net Loss Of $4.3 Million For Q2 2010
May 05, 2010: Flamel Reports Net Loss Of $4 Million For Q1 2010
Mar 08, 2010: Flamel Reports Net Loss Of $5.7 Million For Q4 2009
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Flamel Technologies S.A., Key Facts
Flamel Technologies S.A., Key Employees
Flamel Technologies S.A., Key Employee Biographies
Flamel Technologies S.A., Major Products and Services
Flamel Technologies S.A., Number of Pipeline Products by Therapy Area
Flamel Technologies S.A., Number of Pipeline Products by Development Stage
Flamel Technologies S.A., Pipeline Products By Therapy Area and Development Phase
Flamel Technologies S.A., History
Flamel Technologies S.A., Subsidiaries
Flamel Technologies S.A., Key Manufacturing Facilities
Flamel Technologies S.A., Key Competitors
Flamel Technologies S.A., Ratios based on current share price
Flamel Technologies S.A., Annual Ratios
Flamel Technologies S.A., Interim Ratios
Flamel Technologies S.A., Pharmaceuticals & Healthcare, Deals By Year, 2005 to YTD 2011
Flamel Technologies S.A., Pharmaceuticals & Healthcare, Deals By Type, 2005 to YTD 2011
Flamel Technologies S.A., Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Flamel Technologies S.A., Pipeline Products by Therapy Area
Flamel Technologies S.A., Pipeline Products by Development Phase
Flamel Technologies S.A., Performance Chart (2006 - 2010)
Flamel Technologies S.A., Ratio Charts
Flamel Technologies S.A., Pharmaceuticals & Healthcare, Deals By Year, 2005 to YTD 2011
Flamel Technologies S.A., Pharmaceuticals & Healthcare, Deals by Type, 2005 to YTD 2011
Companies Mentioned
Enzon Pharmaceuticals, Inc.
ANDRX Corporation
Ambrx, Inc.
DURECT Corporation
Nektar Therapeutics
Human Genome Sciences, Inc.
Depomed, Inc.
SkyePharma PLC
Alkermes, Inc.
ANDRX Corporation
Ambrx, Inc.
DURECT Corporation
Nektar Therapeutics
Human Genome Sciences, Inc.
Depomed, Inc.
SkyePharma PLC
Alkermes, Inc.
Ordering:
Order Online - visit http://www.researchandmarkets.com/reports/1582661
Order by Fax - using the order form below
Order By Post - print the order form below and send to
Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.
Page 1 of 2
Printed Thursday, May 23, 2013
1:38:50 PM
1:38:50 PM
Fax order form
To place a fax order simply print this form, fill in and fax the completed form to the number below. If you have any questions please email help@researchandmarkets.net
Order information
Please verify that the product information is correct and select the format you require.
Product name
Flamel Technologies S.A. (FLML) - Financial and Strategic SWOT Analysis Review
Web Address
http://www.researchandmarkets.com/reports/1322600
Office Code
OC8DIQSONQUOXW
Report Formats
Please enter the quantity of the report format you require.
| Format | Quantity | Price | Electronic (PDF) - Site License |
|
EURO€ 192.00 |
|---|---|---|
| Electronic (PDF) - Enterprisewide |
|
EURO€ 288.00 |
| Electronic (PDF) - Single User |
|
EURO€ 96.00 |
Contact information
Please enter all the information below in block capitals.
Title:
Mr
Mrs
Dr
Miss
Ms
Prof
Mrs
Dr
Miss
Ms
Prof
First Name:
Last Name:
Email Address:
Job Title:
Organisation:
Address:
City:
Postal / Zip Code:
Country:
Phone Number:
Fax Number:
Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)
Page 2 of 2
Printed Thursday, May 23, 2013
1:38:50 PM
1:38:50 PM
Payment information
Please indicate the payment method you would like to use by selecting the appropriate box.
Pay by Credit Card:
American Express
Diners Club
Master Card
Visa
Cardholder's Name:
Cardholder's Signature:
Expiry Date:
/
Card Number:
CVV Security Code:
Issue date:
/ (Diners Club only)
Pay by Check:
Please post the check, accompanied by this form, to:
Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.
Pay by Wire Transfer:
Please transfer funds to:
Account Number:
83313083
Sort Code:
98-53-30
Swift Code:
ULSBIE2D
IBAN Number:
IE78ULSB98533083313083
Bank Address:
Ulster Bank,
27-35 Main Street
Blackrock,
Co. Dublin
Ireland.
27-35 Main Street
Blackrock,
Co. Dublin
Ireland.
If you have a Marketing Code please enter it below:
Marketing Code:
Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp